azomycin has been researched along with oxazolidin-2-one in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.33) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 15 (62.50) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lang, R | 1 |
| Kessler, HJ; Schulz, V; Wagener, B | 1 |
| Stier, MA; Suto, MJ; Werbel, LM | 1 |
| Crabb, C | 1 |
| Andries, K; Chauffour, A; Jarlier, V; Ji, B | 1 |
| Chauffour, A; Jarlier, V; Ji, B; Lefrançois, S; Robert, J; Truffot, C | 1 |
| Nau, JY | 1 |
| Mishra, NN; Sahu, DP; Shukla, PK; Varshney, V | 1 |
| Nuermberger, EL; Spigelman, MK; Yew, WW | 1 |
| Adibpour, N; Faramarzi, MA; Firoozpour, L; Foroumadi, A; Khalaj, A; Nakhjiri, M; Negahbani, AS; Rajabalian, S; Samadi, N; Samadizadeh, M; Shafiee, A | 1 |
| Campbell, S; Jakubiec, W; Ladutko, L; Miller, PF; Mitton-Fry, M; Paige, D; Silvia, A; Wallis, RS | 1 |
| Amoabeng, O; Andries, K; Mdluli, KE; Minkowski, A; Nuermberger, EL; Peloquin, CA; Taylor, D; Wallis, RS; Williams, K | 1 |
| Jeong, BH; Koh, WJ; Kwon, YS | 1 |
| Andersson, J; Axelsson-Robertson, R; Keshavjee, S; Lutckii, A; Maeurer, M; Master, I; Parida, SK; Rao, MV; Singh, N; Zumla, A | 1 |
| Chang, KC; Heyckendorf, J; Lange, C; Olaru, ID; von Groote-Bidlingmaier, F; Yew, WW | 1 |
| Keum, YS; Park, SW; Patel, RV | 1 |
| Betoudji, F; Converse, PJ; Dartois, V; Li, SY; Mdluli, KE; Mendel, CM; Nuermberger, EL; Tasneen, R; Tyagi, S; Williams, K; Yang, T | 1 |
| Bruhn, DF; Lee, RE; Lenaerts, AJ; Liu, J; Scherman, MS; Singh, AP; Yang, L | 1 |
| Baillie, TA; Cyrus Khojasteh, S; Dalvie, D; Rietjens, IM | 1 |
| Bujalska-Zadrozny, M; Pstragowski, M; Zbrzezna, M | 1 |
| Nair, SG; Patel, DB; Patel, HD; Rathwa, SK; Vasava, MS | 1 |
| Fattorini, L; Giannoni, F; Iacobino, A; Pardini, M; Piccaro, G | 1 |
| Cooper, CB; Denny, WA; Ding, CZ; Ding, J; He, S; Lu, Y; Lynch, AS; Ma, Z; Upton, AM; Wan, D; Wang, X; Yuan, Y; Zhang, Q; Zhuang, Z | 1 |
| Betoudji, F; Converse, PJ; Fotouhi, N; Lee, J; Li, SY; Mdluli, K; Nuermberger, EL; Upton, A | 1 |
8 review(s) available for azomycin and oxazolidin-2-one
| Article | Year |
|---|---|
Current development and future prospects in chemotherapy of tuberculosis.
Topics: Adamantane; Animals; Antitubercular Agents; Carbapenems; Clinical Trials as Topic; Diarylquinolines; Drug Delivery Systems; Ethylenediamines; Fluoroquinolones; Humans; Isonicotinic Acids; Mice; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Patient Compliance; Pyrroles; Quinolines; Rifamycins; Tuberculosis, Pulmonary | 2010 |
Tuberculosis: clinical trials and new drug regimens.
Topics: Acetamides; Adamantane; Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Drug Administration Schedule; Drug Design; Ethylenediamines; Female; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Male; Moxifloxacin; Nitroimidazoles; Oxazoles; Oxazolidinones; Spiro Compounds; Thiazines; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2014 |
Totally drug-resistant tuberculosis and adjunct therapies.
Topics: Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Genotype; Global Health; Host-Pathogen Interactions; Humans; Mutation; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones | 2015 |
Novel drugs against tuberculosis: a clinician's perspective.
Topics: Adamantane; Antitubercular Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diarylquinolines; Drug Therapy, Combination; Ethylenediamines; Extensively Drug-Resistant Tuberculosis; Female; Follow-Up Studies; Humans; Male; Nitroimidazoles; Oxazoles; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2015 |
Nitroimidazoles, Quinolones and Oxazolidinones as Fluorine Bearing Antitubercular Clinical Candidates.
Topics: Animals; Antitubercular Agents; Drug Discovery; Fluorine; Humans; Nitroimidazoles; Oxazolidinones; Quinolones; Tuberculosis | 2015 |
Biotransformation and bioactivation reactions - 2015 literature highlights.
Topics: Acetaminophen; Allylbenzene Derivatives; Aniline Compounds; Animals; Anisoles; Benzbromarone; Biotransformation; Humans; Imidazoles; Niacinamide; Nitroimidazoles; Nitrosamines; Oxazoles; Oxazolidinones; Peroxides; Pyrazines; Pyrazoles; Pyridazines; Pyridines; Pyridones; Pyrimidinones; Thiophenes; Triazoles | 2016 |
ADVANCES IN PHARMACOTHERAPY OF TUBERCULOSIS.
Topics: Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Humans; Nitroimidazoles; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2017 |
Development of new drug-regimens against multidrug-resistant tuberculosis.
Topics: Adamantane; Antitubercular Agents; Diarylquinolines; Drug Development; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Ethylenediamines; Humans; Isoniazid; Macrolides; Medication Adherence; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 2019 |
16 other study(ies) available for azomycin and oxazolidin-2-one
| Article | Year |
|---|---|
Mammalian spot test with moxnidazole, a 5-nitroimidazole.
Topics: Animals; Embryo, Mammalian; Female; Genotype; Mice; Mutagens; Nitroimidazoles; Oxazoles; Oxazolidinones; Pigmentation; Pregnancy | 1978 |
[Pharmacokinetics of the trichomonacidal agent ZK 25 095 in 6 normal subjects following intravenous and oral administration (author's transl)].
Topics: Administration, Oral; Adult; Antitrichomonal Agents; Bacillus subtilis; Biological Assay; Chromatography, Thin Layer; Humans; Injections, Intravenous; Kinetics; Male; Middle Aged; Nitroimidazoles; Oxazolidinones | 1976 |
Dual-function radiosensitizers. Alpha-[[(2-bromoethyl)amino]methyl]-2-nitro-1H-imidazole-1-ethanol and related compounds: preparation via an aziridine equivalent.
Topics: Acetates; Acetic Acid; Aziridines; Chemical Phenomena; Chemistry; Esterification; Molecular Structure; Nitroimidazoles; Oxazoles; Oxazolidinones; Prodrugs; Radiation-Sensitizing Agents | 1991 |
A new TB drug by 2010--or sooner?
Topics: Anti-Infective Agents; Antitubercular Agents; Directly Observed Therapy; Drug Evaluation; Drug Therapy, Combination; Fluoroquinolones; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones | 2002 |
Bactericidal activities of R207910 and other newer antimicrobial agents against Mycobacterium leprae in mice.
Topics: Acetamides; Animals; Anti-Infective Agents; Aza Compounds; Diarylquinolines; Female; Fluoroquinolones; Leprosy; Linezolid; Mice; Moxifloxacin; Mycobacterium leprae; Nitroimidazoles; Oxazolidinones; Quinolines | 2006 |
In vitro and in vivo activities of rifampin, streptomycin, amikacin, moxifloxacin, R207910, linezolid, and PA-824 against Mycobacterium ulcerans.
Topics: Acetamides; Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Colony Count, Microbial; Diarylquinolines; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Foot; In Vitro Techniques; Linezolid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Nitroimidazoles; Oxazolidinones; Quinolines; Rifampin; Streptomycin; Survival Analysis; Time Factors | 2006 |
[Some new antitubercular agents].
Topics: Acetamides; Antitubercular Agents; Diarylquinolines; Humans; Linezolid; Nitroimidazoles; Oxazoles; Oxazolidinones; Quinolines | 2008 |
Synthesis of nitroimidazole derived oxazolidinones as antibacterial agents.
Topics: Alkylation; Animals; Anti-Bacterial Agents; Bacteria; Cell Line; Cell Survival; Drug Resistance, Bacterial; Mice; Nitroimidazoles; Oxazolidinones | 2010 |
Discovery of a novel nitroimidazolyl-oxazolidinone hybrid with potent anti Gram-positive activity: Synthesis and antibacterial evaluation.
Topics: Animals; Anti-Bacterial Agents; Drug Discovery; Gram-Positive Bacteria; Mice; NIH 3T3 Cells; Nitroimidazoles; Oxazolidinones | 2011 |
Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide.
Topics: Adamantane; Antitubercular Agents; Diarylquinolines; Drug Monitoring; Drug Therapy, Combination; Ethylenediamines; Extensively Drug-Resistant Tuberculosis; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Quinolines; Reproducibility of Results; Time Factors | 2012 |
Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2012 |
Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis.
Topics: Animals; Antitubercular Agents; Bacterial Load; Diarylquinolines; Disease Models, Animal; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Linezolid; Lung; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nitroimidazoles; Organophosphates; Oxazoles; Oxazolidinones; Pyrazinamide; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |
Synthesis and evaluation of pretomanid (PA-824) oxazolidinone hybrids.
Topics: Animals; Antitubercular Agents; Chronic Disease; Disease Models, Animal; Mice; Mice, Inbred C57BL; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Tuberculosis | 2016 |
The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
Topics: Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Hydrogen-Ion Concentration; Hypoxia; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis | 2019 |
Synergistic Activity of Nitroimidazole-Oxazolidinone Conjugates against Anaerobic Bacteria.
Topics: Antitubercular Agents; Bacteria, Anaerobic; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Linezolid; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2020 |
Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model.
Topics: Animals; Antitubercular Agents; Diarylquinolines; Linezolid; Mice; Nitroimidazoles; Oxazolidinones; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2023 |